Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure.
Yu Y, Zhang ZH, Wei SG, Weiss RM, Felder RB.
Hypertension. 2012 Feb;59(2):477-84. Epub 2011 Nov 14.
Related citations
Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure.
Xiao L, Gao L, Lazartigues E, Zucker IH.
Hypertension. 2011 Dec;58(6):1057-65. Epub 2011 Oct 24.
Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure.
Zheng H, Liu X, Li Y, Sharma NM, Patel KP.
Hypertension. 2011 Nov;58(5):966-73. Epub 2011 Oct 3.
Aging, blood pressure, and heart failure: what are the connections?
Franklin SS, Levy D.
Hypertension. 2011 Nov;58(5):760-2. Epub 2011 Sep 26. No abstract available.
Isolated diastolic hypotension and incident heart failure in older adults.
Guichard JL, Desai RV, Ahmed MI, Mujib M, Fonarow GC, Feller MA, Ekundayo OJ, Bittner V, Aban IB, White M, Aronow WS, Love TE, Bakris GL, Zieman SJ, Ahmed A.
Hypertension. 2011 Nov;58(5):895-901. Epub 2011 Sep 26.
Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure.
Kar S, Gao L, Belatti DA, Curry PL, Zucker IH.
Hypertension. 2011 Oct;58(4):627-34. Epub 2011 Aug 15.
Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats.
Biancardi VC, Son SJ, Sonner PM, Zheng H, Patel KP, Stern JE.
Hypertension. 2011 Sep;58(3):454-63. Epub 2011 Aug 8.
AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.
Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, Xin Y, Hall JL, Viollet B, Bache RJ, Huang Y, Chen Y.
Hypertension. 2011 Oct;58(4):696-703. Epub 2011 Aug 8.
Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
Rademaker MT, Charles CJ, Ellmers LJ, Lewis LK, Nicholls MG, Richards AM.
Hypertension. 2011 Jun;57(6):1136-44. Epub 2011 May 2.
Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.
Lother A, Berger S, Gilsbach R, Rösner S, Ecke A, Barreto F, Bauersachs J, Schütz G, Hein L.
Hypertension. 2011 Apr;57(4):746-54. Epub 2011 Feb 14.
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.
Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB.
Hypertension. 2011 Apr;57(4):689-94. Epub 2011 Mar 7.
Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition.
Birkenfeld AL, Adams F, Schroeder C, Engeli S, Jordan J.
Hypertension. 2011 Feb;57(2):e4-5. Epub 2010 Dec 13. No abstract available.
Iron repletion in heart failure patients.
Silverberg D, Iaina A, Wexler D, Schwartz D.
Hypertension. 2011 Mar;57(3):381-2. Epub 2011 Jan 24. No abstract available.
The impact of exercise training on conduit artery wall thickness and remodeling in chronic heart failure patients.
Maiorana AJ, Naylor LH, Exterkate A, Swart A, Thijssen DH, Lam K, O'Driscoll G, Green DJ.
Hypertension. 2011 Jan;57(1):56-62. Epub 2010 Nov 8.
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension?
de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, Girfoglio D, Iovino GL, Trimarco B, De Luca N.
Hypertension. 2010 Jul;56(1):99-104. Epub 2010 May 24.
Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction.
Seymour EM, Bennink MR, Watts SW, Bolling SF.
Hypertension. 2010 May;55(5):1179-85. Epub 2010 Mar 15.
Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance.
Zhang Z, Dzau VJ.
Hypertension. 2010 May;55(5):1086-7. Epub 2010 Mar 15. No abstract available.
Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction.
González A, López B, Querejeta R, Zubillaga E, Echeverría T, Díez J.
Hypertension. 2010 Jun;55(6):1418-24. Epub 2010 Apr 19.
Microenvironment and macroenvironment in hypertensive hearts: boundaries and silos--can we pick and treat diastolic heart failure?
Hunyor SN, Jackson CJ.
Hypertension. 2010 Jun;55(6):1312-3. Epub 2010 Apr 19. No abstract available.
Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect.
Esler M.
Hypertension. 2010 May;55(5):1090-1. Epub 2010 Apr 5. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on